Company
United StatesAlexion Pharmaceuticals, Inc., Boston, MA – FDA Inspections
Inspection records and compliance data for Alexion Pharmaceuticals, Inc. in Boston, Massachusetts. 7 FDA inspections on record, 2 Form 483s, 1 warning letter, last inspected July 28, 2026.
Company Profile
This profile covers Alexion Pharmaceuticals, Inc. based in Boston, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 0
- VAI
- 2
- NAI
- 3
- Unclassified
- 2
- Form 483s
- 2
- Warning letters
- 1
First inspected December 17, 2021. Last inspected July 28, 2026.
Most cited issue areas
- Failure to comply with REMS Implementation System1 inspection
- Failure to develop written procedures1 inspection
- Failure to review ADE information1 inspection
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 28, 2026 | Not classified | Human Drugs | 1330676 |
| July 1, 2026 | Not classified | Human Drugs | 1326206 |
| March 7, 2025 | VAI | Human Drugs · Postmarketing Surveillance and Epidemiology: Human Drugs | 1262947 |
| November 7, 2024 | VAI | Human Drugs · Postmarketing Surveillance and Epidemiology: Human Drugs | 1254018 |
| September 14, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1219061 |
| June 30, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1218199 |
| December 17, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1160097 |
FDA documents
Warning Letters (1)
People (4)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Alexion Pharmaceuticals, Inc.
FEI Number
3014801948
Address
121 Seaport Blvd, Boston, Massachusetts 02210, United States
Country
United States
ID: ff74d8e2-db98-41ca-9f7b-b8e9cb8b4015